Back to results
US 8,044,033 B2Granted
Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer
AssigneeBoard of Regents, The University of Texas System
InventorEdward H. Lin
Life of this patent
Estimating the term…
Abstract
The present invention provides, in certain embodiments, methods for the treatment of colorectal cancer comprising administering a COX-2 inhibitor and fluorocytidine derivative to a human patient. In certain embodiments, a radiation therapy is also administered to the patient.
Claims20
A method for treating cancer in a human patient comprising administering an effective amount of celecoxib and capecitabine to the patient, wherein the cancer is a nodal metastasis of a metastatic colorectal cancer.
Dependencies are inferred from the claim text.